ScienceDex / Researcher record
Pack, Christopher D
- Metaclipse Therapeutics Corporation (no department on record)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
- Rising Star
NIH Funding · FY2022
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2008 | $51,278 | 1 | #38,401 |
| 2013 | $144,759 | 1 | #34,514 |
| 2021 | $1,061,403 | 1 | #8,606 |
| 2022 | $1,032,619 | 3 | #9,389 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20081 record
- FY20131 record
- FY20211 record
- FY2022 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award records by amount
NIH award records listing Pack, Christopher D as a PI. Multi-PI records show the full award amount for context.
- 5R44CA257278-02R44Contact PIClinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer$938.6Kaward amount
- 3R44CA257278-02S1R44Contact PIClinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer$59.4Kaward amount
- 3R44CA257278-01A1S1R44Contact PIClinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer$34.6Kaward amount
Award organization
Organizations that administered FY2022 awards listing Pack, Christopher D as a PI.
FY2022 award administered by Metaclipse Therapeutics Corporation (GA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardMetaclipse Therapeutics Corporation
- 2021$500K Cumulative Funding
- 2021$1M Cumulative Funding
- 2021Entered Top 50% NationallyRanked #8606
- 2022$2M Cumulative Funding